by MyBiosource Editorial Team | Oct 12, 2018 | News
Table of Contents 1. Introduction 2. Hepatitis: Causes and Symptoms 3. Pharmaceutical Industry Advancements 4. Hepatitis B Drugs under Development • Direct-acting drugs • siRNA • TDF Pro Drugs • Entry Inhibitors • Capsid Inhibitors • HBsAg Inhibitors • Antisense...
by MyBiosource Editorial Team | Oct 12, 2018 | News
Table of Contents I. Introduction II. Herpes as a common sexually transmitted infection III. Current treatment for herpes IV. Need for new anti-HSV agents V. Clinical trials for herpes vaccine development VI. Microbicides as alternative strategy • Categorization of...
by MyBiosource Editorial Team | Oct 12, 2018 | News
Table of Contents I. Introduction • Overview of HSV infection • Difference between HSV-1 and HSV-2 II. Prevalence III. Symptoms and Transmission • Symptoms of HSV-1 and HSV-2 infections • Transmission of HSV-1 and HSV-2 infections through contact with infected sores,...
by MyBiosource Editorial Team | Oct 12, 2018 | News
Table of Contents 1. Introduction 2. Herpes Simplex Virus (HSV) Infections 3. Drugs for HSV Infection 4. Vaccines for HSV-2 Infection 5. Topical Microbicides for HSV-2 Infection 6. RNA Interference (RNAi) as a Treatment for HSV-2 Infection 7. Pritelivir – A...
by MyBiosource Editorial Team | Oct 12, 2018 | News
Table of Contents I. Introduction • The four decades of studying HIV • The progress in making HIV manageable II. Screening Landscape • Introduction of 4th generation screening test • Window period of different screening tests • Confirmatory tests for HIV III....
by MyBiosource Editorial Team | Oct 12, 2018 | News
Table of Contents I. Introduction • The need for a functional cure for HIV • Antiretroviral therapy (ART) and its impact on HIV treatment • Definition of a functional cure II. Strategies for HIV cure research • Gene therapy • Immunotherapy • Shock and kill approach...
